Radical Surgery
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Single-arm, Multicenter, Phase II Clinical Study of Camrelizumab Combined With Famitinib in Adjuvant Therapy After Radical Resection of Cervical Cancer (NCT07466901) | Jin LI | 2026-04-01 |
Track Radical Surgery automatically
Every clearance here is in the API, with alerts when new ones post.